ArticleNational science review2019

Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease.

Xiawei Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.